Amgen Inc. buy marge
Start price
21.06.15
/
50%
€141.91
Target price
24.05.16
€160.00
Performance (%)
-3.29%
End price
24.05.16
€134.02
Summary
This prediction ended on 24.05.16 with a price of €134.02. With a performance of -3.29%, the BUY prediction by marge finished with a loss. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | -2.962% | -2.962% | 5.950% | 22.784% |
| iShares Core DAX® | -1.410% | 0.471% | 12.651% | 58.522% |
| iShares Nasdaq 100 | -0.450% | -0.305% | 5.495% | 95.184% |
| iShares Nikkei 225® | -0.224% | 5.529% | 18.894% | 49.093% |
| iShares S&P 500 | -1.095% | -0.774% | 1.350% | 60.886% |
Comments by marge for this prediction
In the thread Amgen Inc. diskutieren
Amgen
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)